Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ

<p>Abstract</p> <p>Background</p> <p>The aim of our study was to investigate the predictive value of the biomarkers interleukin 6 (IL-6), interleukin 10 (IL-10) and lipopolysaccharide-binding protein (LBP) compared with clinical CRB and CRB-65 severity scores in patient...

Full description

Bibliographic Details
Main Authors: Zobel Katrin, Martus Peter, Pletz Mathias W, Ewig Santiago, Prediger Michael, Welte Tobias, Bühling Frank
Format: Article
Language:English
Published: BMC 2012-02-01
Series:BMC Pulmonary Medicine
Subjects:
LBP
CAP
Online Access:http://www.biomedcentral.com/1471-2466/12/6
id doaj-762e6b9860114e9d959c7b6195710f90
record_format Article
spelling doaj-762e6b9860114e9d959c7b6195710f902020-11-24T22:56:53ZengBMCBMC Pulmonary Medicine1471-24662012-02-01121610.1186/1471-2466-12-6Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZZobel KatrinMartus PeterPletz Mathias WEwig SantiagoPrediger MichaelWelte TobiasBühling Frank<p>Abstract</p> <p>Background</p> <p>The aim of our study was to investigate the predictive value of the biomarkers interleukin 6 (IL-6), interleukin 10 (IL-10) and lipopolysaccharide-binding protein (LBP) compared with clinical CRB and CRB-65 severity scores in patients with community-acquired pneumonia (CAP).</p> <p>Methods</p> <p>Samples and data were obtained from patients enrolled into the German CAPNETZ study group. Samples (blood, sputum and urine) were collected within 24 h of first presentation and inclusion in the CAPNETZ study, and CRB and CRB-65 scores were determined for all patients at the time of enrollment. The combined end point representative of a severe course of CAP was defined as mechanical ventilation, intensive care unit treatment and/or death within 30 days. Overall, a total of 1,000 patients were enrolled in the study. A severe course of CAP was observed in 105 (10.5%) patients.</p> <p>Results</p> <p>The highest IL-6, IL-10 and LBP concentrations were found in patients with CRB-65 scores of 3-4 or CRB scores of 2-3. IL-6 and LBP levels on enrollment in the study were significantly higher for patients with a severe course of CAP than for those who did not have severe CAP. In receiver operating characteristic analyses, the area under the curve values for of IL-6 (0.689), IL-10 (0.665) and LPB (0.624) in a severe course of CAP were lower than that of CRB-65 (0.764) and similar to that of CRB (0.69). The accuracy of both CRB and CRB-65 was increased significantly by including IL-6 measurements. In addition, higher cytokine concentrations were found in patients with typical bacterial infections compared with patients with atypical or viral infections and those with infection of unknown etiology. LBP showed the highest discriminatory power with respect to the etiology of infection.</p> <p>Conclusions</p> <p>IL-6, IL-10 and LBP concentrations were increased in patients with a CRB-65 score of 3-4 and a severe course of CAP. The concentrations of IL-6 and IL-10 reflected the severity of disease in patients with CAP. The predictive power of IL-6, IL-10 and LBP for a severe course of pneumonia was lower than that of CRB-65. Typical bacterial pathogens induced the highest LBP, IL-6 and IL-10 concentrations.</p> http://www.biomedcentral.com/1471-2466/12/6Interleukin-6Interleukin-10LBPCAPPneumoniaBiomarkerCytokine
collection DOAJ
language English
format Article
sources DOAJ
author Zobel Katrin
Martus Peter
Pletz Mathias W
Ewig Santiago
Prediger Michael
Welte Tobias
Bühling Frank
spellingShingle Zobel Katrin
Martus Peter
Pletz Mathias W
Ewig Santiago
Prediger Michael
Welte Tobias
Bühling Frank
Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ
BMC Pulmonary Medicine
Interleukin-6
Interleukin-10
LBP
CAP
Pneumonia
Biomarker
Cytokine
author_facet Zobel Katrin
Martus Peter
Pletz Mathias W
Ewig Santiago
Prediger Michael
Welte Tobias
Bühling Frank
author_sort Zobel Katrin
title Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ
title_short Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ
title_full Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ
title_fullStr Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ
title_full_unstemmed Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ
title_sort interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the german competence network capnetz
publisher BMC
series BMC Pulmonary Medicine
issn 1471-2466
publishDate 2012-02-01
description <p>Abstract</p> <p>Background</p> <p>The aim of our study was to investigate the predictive value of the biomarkers interleukin 6 (IL-6), interleukin 10 (IL-10) and lipopolysaccharide-binding protein (LBP) compared with clinical CRB and CRB-65 severity scores in patients with community-acquired pneumonia (CAP).</p> <p>Methods</p> <p>Samples and data were obtained from patients enrolled into the German CAPNETZ study group. Samples (blood, sputum and urine) were collected within 24 h of first presentation and inclusion in the CAPNETZ study, and CRB and CRB-65 scores were determined for all patients at the time of enrollment. The combined end point representative of a severe course of CAP was defined as mechanical ventilation, intensive care unit treatment and/or death within 30 days. Overall, a total of 1,000 patients were enrolled in the study. A severe course of CAP was observed in 105 (10.5%) patients.</p> <p>Results</p> <p>The highest IL-6, IL-10 and LBP concentrations were found in patients with CRB-65 scores of 3-4 or CRB scores of 2-3. IL-6 and LBP levels on enrollment in the study were significantly higher for patients with a severe course of CAP than for those who did not have severe CAP. In receiver operating characteristic analyses, the area under the curve values for of IL-6 (0.689), IL-10 (0.665) and LPB (0.624) in a severe course of CAP were lower than that of CRB-65 (0.764) and similar to that of CRB (0.69). The accuracy of both CRB and CRB-65 was increased significantly by including IL-6 measurements. In addition, higher cytokine concentrations were found in patients with typical bacterial infections compared with patients with atypical or viral infections and those with infection of unknown etiology. LBP showed the highest discriminatory power with respect to the etiology of infection.</p> <p>Conclusions</p> <p>IL-6, IL-10 and LBP concentrations were increased in patients with a CRB-65 score of 3-4 and a severe course of CAP. The concentrations of IL-6 and IL-10 reflected the severity of disease in patients with CAP. The predictive power of IL-6, IL-10 and LBP for a severe course of pneumonia was lower than that of CRB-65. Typical bacterial pathogens induced the highest LBP, IL-6 and IL-10 concentrations.</p>
topic Interleukin-6
Interleukin-10
LBP
CAP
Pneumonia
Biomarker
Cytokine
url http://www.biomedcentral.com/1471-2466/12/6
work_keys_str_mv AT zobelkatrin interleukin6lipopolysaccharidebindingproteinandinterleukin10inthepredictionofriskandetiologicpatternsinpatientswithcommunityacquiredpneumoniaresultsfromthegermancompetencenetworkcapnetz
AT martuspeter interleukin6lipopolysaccharidebindingproteinandinterleukin10inthepredictionofriskandetiologicpatternsinpatientswithcommunityacquiredpneumoniaresultsfromthegermancompetencenetworkcapnetz
AT pletzmathiasw interleukin6lipopolysaccharidebindingproteinandinterleukin10inthepredictionofriskandetiologicpatternsinpatientswithcommunityacquiredpneumoniaresultsfromthegermancompetencenetworkcapnetz
AT ewigsantiago interleukin6lipopolysaccharidebindingproteinandinterleukin10inthepredictionofriskandetiologicpatternsinpatientswithcommunityacquiredpneumoniaresultsfromthegermancompetencenetworkcapnetz
AT predigermichael interleukin6lipopolysaccharidebindingproteinandinterleukin10inthepredictionofriskandetiologicpatternsinpatientswithcommunityacquiredpneumoniaresultsfromthegermancompetencenetworkcapnetz
AT weltetobias interleukin6lipopolysaccharidebindingproteinandinterleukin10inthepredictionofriskandetiologicpatternsinpatientswithcommunityacquiredpneumoniaresultsfromthegermancompetencenetworkcapnetz
AT buhlingfrank interleukin6lipopolysaccharidebindingproteinandinterleukin10inthepredictionofriskandetiologicpatternsinpatientswithcommunityacquiredpneumoniaresultsfromthegermancompetencenetworkcapnetz
_version_ 1725652843138908160